These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 5125053

  • 21. [Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa].
    Ferraris M.
    Minerva Med; 1971 Oct 31; 62(82):3971-3. PubMed ID: 5125056
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects].
    Puca FM, Pigneri MT.
    Boll Soc Ital Biol Sper; 1972 May 15; 48(9):237-40. PubMed ID: 5070096
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Therapy of Parkinsonism. II].
    Clin Ter; 1974 Nov 30; 71(4):367-87. PubMed ID: 4617648
    [No Abstract] [Full Text] [Related]

  • 32. [Parkinsonism].
    Kadykov AS.
    Med Sestra; 1980 Jan 30; 39(1):21-4. PubMed ID: 6898782
    [No Abstract] [Full Text] [Related]

  • 33. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
    MMW Fortschr Med; 2001 May 28; 143 Suppl 2():93. PubMed ID: 11434272
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Amantadine in the treatment of Parkinson's disease].
    Giombini S, Solero CL, Bazzan A, Ferrari P, Robotti E.
    Fracastoro; 1970 May 28; 63(6):869-81. PubMed ID: 5519639
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes].
    Kluzer G, Lampo B.
    Minerva Med; 1971 Oct 31; 62(82):4013-4. PubMed ID: 5125067
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Psychotic reactions in parkinsonian patients treated with amantadine].
    Fernández Martín F.
    Rev Clin Esp; 1970 Aug 31; 118(4):371-2. PubMed ID: 5486104
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.